Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

139 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Inappropriate calibration and optimisation of pan-keratin (pan-CK) and low molecular weight keratin (LMWCK) immunohistochemistry tests: Canadian Immunohistochemistry Quality Control (CIQC) experience.
Copete M, Garratt J, Gilks B, Pilavdzic D, Berendt R, Bigras G, Mitchell S, Lining LA, Cheung C, Torlakovic EE. Copete M, et al. Among authors: torlakovic ee. J Clin Pathol. 2011 Mar;64(3):220-5. doi: 10.1136/jcp.2010.085258. Epub 2011 Jan 22. J Clin Pathol. 2011. PMID: 21258091
The laboratory score/reference method score ratio (LSRSR) is a novel tool for monitoring laboratory performance in immunohistochemistry proficiency testing of hormone receptors in breast cancer: the CIQC experience.
Cheung CC, Neufeld H, Lining LA, Pilavdzic D, Copete M, Garratt J, Gilks B, Torlakovic EE. Cheung CC, et al. Among authors: torlakovic ee. Am J Clin Pathol. 2011 Jul;136(1):67-73. doi: 10.1309/AJCPQ6I9GHJMCBEV. Am J Clin Pathol. 2011. PMID: 21685033
Canadian Association of Pathologists-Association canadienne des pathologistes National Standards Committee/Immunohistochemistry: best practice recommendations for standardization of immunohistochemistry tests.
Canadian Association of Pathologists-Association canadienne des pathologistes National Standards Committee; Torlakovic EE, Riddell R, Banerjee D, El-Zimaity H, Pilavdzic D, Dawe P, Magliocco A, Barnes P, Berendt R, Cook D, Gilks B, Williams G, Perez-Ordonez B, Wehrli B, Swanson PE, Otis CN, Nielsen S, Vyberg M, Butany J. Canadian Association of Pathologists-Association canadienne des pathologistes National Standards Committee, et al. Among authors: torlakovic ee. Am J Clin Pathol. 2010 Mar;133(3):354-65. doi: 10.1309/AJCPDYZ1XMF4HJWK. Am J Clin Pathol. 2010. PMID: 20154273
Canadian Association of Pathologists-Association canadienne des pathologistes National Standards Committee for High Complexity Testing/Immunohistochemistry: guidelines for the preparation, release, and storage of unstained archived diagnostic tissue sections for immunohistochemistry.
Cheung CC, Banerjee D, Barnes PJ, Berendt RC, Butany J, Canil S, Clarke BA, El-Zimaity H, Garratt J, Geldenhuys L, Gilks CB, Manning L, Mengel M, Perez-Ordonez B, Pilavdzic D, Riddell R, Swanson PE, Torlakovic EE. Cheung CC, et al. Among authors: torlakovic ee. Am J Clin Pathol. 2014 Nov;142(5):629-33. doi: 10.1309/AJCP77GXYVEQXMXT. Am J Clin Pathol. 2014. PMID: 25319977
Developing ALK Immunohistochemistry and In Situ Hybridization Proficiency Testing for Non-Small Cell Lung Cancer in Canada: Canadian Immunohistochemistry Quality Control Challenges and Successes.
Cheung CC, Garratt J, Won J, Cutz JC, Gilks BC, Tsao M, Torlakovic EE. Cheung CC, et al. Among authors: torlakovic ee. Appl Immunohistochem Mol Morphol. 2015 Nov-Dec;23(10):677-81. doi: 10.1097/PAI.0000000000000267. Appl Immunohistochem Mol Morphol. 2015. PMID: 26551338 Clinical Trial.
Diagnostic Accuracy in Fit-for-Purpose PD-L1 Testing.
Cheung CC, Lim HJ, Garratt J, Won J, Gilks CB, Torlakovic EE. Cheung CC, et al. Among authors: torlakovic ee. Appl Immunohistochem Mol Morphol. 2019 Apr;27(4):251-257. doi: 10.1097/PAI.0000000000000734. Appl Immunohistochem Mol Morphol. 2019. PMID: 30789848 Clinical Trial.
Implementation of a Canadian external quality assurance program for breast cancer biomarkers: an initiative of Canadian Quality Control in immunohistochemistry (cIQc) and Canadian Association of Pathologists (CAP) National Standards Committee/Immunohistochemistry.
Terry J, Torlakovic EE, Garratt J, Miller D, Köbel M, Cooper J, Bahzad S, Pilavdzic D, O'Malley F, O'Brien AE, SenGupta S, Alport E, Têtu B, Knight B, Pettigrew NM, Berendt R, Wolber R, Trotter MJ, Riddell RH, Gaboury L, Elms F, Magliocco A, Barnes P, Gown AM, Gilks CB. Terry J, et al. Among authors: torlakovic ee. Appl Immunohistochem Mol Morphol. 2009 Oct;17(5):375-82. doi: 10.1097/PAI.0b013e31819adacf. Appl Immunohistochem Mol Morphol. 2009. PMID: 19363444
Canadian Multicenter Project on Standardization of Programmed Death-Ligand 1 Immunohistochemistry 22C3 Laboratory-Developed Tests for Pembrolizumab Therapy in NSCLC.
Torlakovic E, Albadine R, Bigras G, Boag A, Bojarski A, Cabanero M, Camilleri-Broët S, Cheung C, Couture C, Craddock KJ, Cutz JC, Dhamanaskar P, Fiset PO, Hossain M, Hwang DM, Ionescu D, Itani D, Kelly MM, Kwan K, Lim HJ, Nielsen S, Qing G, Sekhon H, Spatz A, Waghray R, Wang H, Xu Z, Tsao MS. Torlakovic E, et al. J Thorac Oncol. 2020 Aug;15(8):1328-1337. doi: 10.1016/j.jtho.2020.03.029. Epub 2020 Apr 15. J Thorac Oncol. 2020. PMID: 32304736 Free article.
139 results